Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

How Might Turkey Contain Its Rising Health Care Bill?

Executive Summary

As Turkey’s government discloses health care and drug budget plans for 2017, it is becoming clear that controlling the rise in national costs while meeting needs will remain central to policies, prompting the consideration of a variety of approaches.

You may also be interested in...



Turkish Decree Places New Caps On Drug Price Increases

In order to help curb the drugs bill, the Turkish Social Security Institution has decided to restrict the level of price increases that can be made on pharmaceutical products when the prices of those products are increased in reference or non-reference countries.

Sovaldi Among New HCV Drugs In Turkey Reimbursement Pact

Turkey’s public health payer has added three new hepatitis C drugs to the reimbursement list through a special deal with manufacturers, although the price the SGK will be paying to the companies is not being revealed.

Medtech Procurement A Victim Of Turkey’s Ongoing Economic Troubles

The devaluation of the Turkish Lira since May is making imports of medical devices more expensive and putting hospital procurement under renewed pressure. The local medtech industry associations TUMDEF and ARTED describe the problems  ̶  and the solutions  ̶  to Medtech Insight.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS119528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel